Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
TREM2 is a receptor for lipids expressed in microglia. The R47H variant of human TREM2 impairs ligand binding and increases Alzheimer’s disease (AD) risk. In mouse models of amyloid β (Aβ) accumulation, defective TREM2 function affects microglial response to Aβ plaques, exacerbating tissue damage, whereas TREM2 overexpression attenuates pathology. Thus, AD may benefit from TREM2 activation. Here, we examined the impact of an anti-human TREM2 agonistic mAb, AL002c, in a mouse AD model expressing either the common variant (CV) or the R47H variant of TREM2. Single-cell RNA-seq of microglia after acute systemic administration of AL002c showed induction of proliferation in both CV- and R47H-transgenic mice. Prolonged administration of AL002c reduced filamentous plaques and neurite dystrophy, impacted behavior, and tempered microglial inflammatory response. We further showed that a variant of AL002c is safe and well tolerated in a first-in-human phase I clinical trial and engages TREM2 based on cerebrospinal fluid biomarkers. We conclude that AL002 is a promising candidate for AD therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures














Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AL002 (27) is a TREM2-specific monoclonal antibody that activates TREM2 to enhance microglial function, thereby reducing Aβ plaque formation and attenuating neurite dystrophy.474”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [474]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“enhancing TREM2 signaling by TREM2 agonist antibody, direct delivery of the TREM2 gene, or stimulating other pathways to increase TREM2 expression in the brains of AD mice enhanced Aβ phagocytosis and improved cognitive behaviors.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [172]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Emerging evidence has shown that TREM2 activation increased Aβ phagocytosis, relieved neuroinflammation, and improved cognitive behavior in AD mouse models.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [172]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In an AD mouse model, administration of AL002c, a variant of the AL002 antibody, attenuated tau plaques and neurite dystrophy, improved behavior, and reduced microglial inflammation.537”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [537]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The opposite phenotypes observed in PLCG2 KO iMGs and Plcγ2-P522R KI mice also support the notion to therapeutically stimulate TREM2 functions [6, 16, 17, 43].”
From The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions (2020) · cites this paper as [17]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Self-citationDissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem, A., Rodman, C., Lian, C., Murphy, G., et al. (2016) · Science · doi:10.1126/science.aad0501 · Cited by 4,944
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 1×
“In this model, plaques become clearly detectable at 3–4 mo of age and continue to grow for several months (Oakley et al., 2006).”
MethodAlzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Single-cell transcriptomic analysis of Alzheimer’s disease
Mathys, H., Davila-Velderrain, J., Peng, Z., Gao, F., Mohammadi, S., Young, J. Z., Menon, M., He, L., Abdurrob, F., Jiang, X., et al. (2019) · Nature · doi:10.1038/s41586-019-1195-2 · Cited by 2,568
Cited by
Items 201–300 of 579
Therapeutic Spp1 silencing in TREM2+ cardiac macrophages suppresses atrial fibrillation
Momin, N., Pabel, S., Rudra, A., Kumowski, N., Lee, I., Seung, H., Mentkowski, K. I., Bapat, A. C., Yamazoe, M., Stengel, L., et al. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-026-00806-6 · Cited by 29
Shi, W., Zhang, J., Shang, Z., Zhang, Y., Xia, Y., Fu, H., & Yu, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.969127 · Cited by 32
Cooper, O., Hallett, P. J., & Isacson, O. (2022) · FEBS Journal · doi:10.1111/febs.16638 · Cited by 28
CRISPR-Cas9 in Alzheimer’s disease: Therapeutic trends, modalities, and challenges
Chacko, L., Chaudhary, A., Singh, B., Dewanjee, S., & Kandimalla, R. J. L. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103652 · Cited by 29
Loss of ATG7 in microglia impairs UPR, triggers ferroptosis, and weakens amyloid pathology control
Cai, Z., Wang, S., Cao, S. “., Chen, Y., Penati, S., Peng, V., Yuede, C. M., Beatty, W. L., Lin, K., Zhu, Y., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20230173 · Cited by 27
Self-citationDecoding TREM2 Signaling Pathways: Linking Macrophage Glycolysis to Inflammatory Diseases in the CNS
Che, Y., Yu, Z., Ji, S., & Yang, D. (2026) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200527 · Cited by 27
Ibach, M., Mathews, M., Linnartz‐Gerlach, B., Theil, S., Kumar, S., Feederle, R., Brüstle, O., Neumann, H., & Walter, J. (2020) · Glia · doi:10.1002/glia.23953 · Cited by 27
The prevalence and risk factors for cognitive impairment in obesity and NAFLD
Wernberg, C. W., Grønkjær, L. L., Jacobsen, B. G., Chandran, V. I., Krag, A. A., Graversen, J. H., Weißenborn, K., Vilstrup, H., & Lauridsen, M. M. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000203 · Cited by 28
Zhao, Y., Guo, Q., Tian, J., Liu, W., & Wang, X. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102596 · Cited by 26
Beckmann, N., Neuhaus, A., Zurbruegg, S., Volkmer, P., Patiño, C., Joller, S., Feuerbach, D., Doelemeyer, A., Schweizer, T., Rudin, S., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02671-z · Cited by 25
Wißfeld, J., Assale, T. A., Cuevas-Ríos, G., Liao, H., & Neumann, H. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1330874 · Cited by 24
Alrouji, M., Alshammari, M. S., Syed, T., & Shamsi, A. (2025) · Antioxidants · doi:10.3390/antiox14070774 · Cited by 26
TREM2 in MASH: integrating lipid metabolism and immune response
Shi, S., Zhou, Y. Y., Zhang, H., & Zhang, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1604837 · Cited by 28
TREM2 in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential
Li, L., Zheng, X., Ma, H., Zhu, M., Li, X., Sun, X., & Feng, X. (2025) · Cells · doi:10.3390/cells14171387 · Cited by 25
Petrisko, T. J., Gómez-Arboledas, Á., & Tenner, A. J. (2021) · Advances in immunology · doi:10.1016/bs.ai.2021.09.003 · Cited by 23
Stress-induced red nucleus attenuation induces anxiety-like behavior and lymph node CCL5 secretion
Shi, D., Zhang, Y.-D., Zhang, S., Liao, B.-B., Chu, M., Su, S., Zhuo, K., Hu, H., Zhang, C., & Wang, Z. (2023) · Nature Communications · doi:10.1038/s41467-023-42814-1 · Cited by 25
Shi, J., & Huang, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010016 · Cited by 23
Akyüz, E., Aslan, F. Ş., Gokce, E., Ilmaz, O., Topcu, F., & Kakac, S. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16541 · Cited by 25
Circadian rhythm, microglia-mediated neuroinflammation, and Alzheimer’s disease
Geng, F., Zhao, N., & Ren, Q. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106044 · Cited by 25
TREM2 Agonism with a Monoclonal Antibody Attenuates Tau Pathology and Neurodegeneration
Fassler, M., Benaim, C., & George, J. (2023) · Cells · doi:10.3390/cells12111549 · Cited by 22
Shao, Q., Chen, S., Zheng, Y., Xu, W., Chen, J., Shao, W., Wang, Q., Li, C., & Wang, X. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01109 · Cited by 24
Lin, S., Zhan, Y., Wang, R., & Pei, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1616899 · Cited by 26
Giampietri, L., Belli, E., Beatino, M. F., Giannoni, S., Palermo, G., Campese, N., Tognoni, G., Siciliano, G., Ceravolo, R., Luca, C. D., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12040796 · Cited by 25
A Review of the Pathogenesis and Chinese Medicine Intervention of Alzheimer's Disease
Zhao, J., Yang, J., Li, D., Wang, F., & Li, L. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2201002 · Cited by 24
Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer’s Disease
Tamburini, B., Badami, G. D., Manna, M. P. L., Azgomi, M. S., Caccamo, N., & Dieli, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241511922 · Cited by 25
Alzheimer’s disease: an axonal injury disease?
Liang, D., & Zhang, Z. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1264448 · Cited by 23
Immunotherapy: An emerging treatment option for neurodegenerative diseases
Mukherjee, A., Biswas, S., & Roy, I. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.103974 · Cited by 23
Alzheimer’s Disease Genetics: A Dampened Microglial Response?
Chatila, Z. K., & Bradshaw, E. M. (2021) · The Neuroscientist · doi:10.1177/10738584211024531 · Cited by 25
Novel approaches to increase synaptic resilience as potential treatments for Alzheimer’s disease
Pham, A. Q., & Dore, K. (2023) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2022.03.032 · Cited by 21
Pathways linking Alzheimer’s disease risk genes expressed highly in microglia
Hodges, A. K., Piers, T. M., Collier, D., Cousins, O., & Pocock, J. M. (2021) · Neuroimmunology and Neuroinflammation · doi:10.20517/2347-8659.2020.60 · Cited by 21
TREM2 signaling in Parkinson’s disease: Regulation of microglial function and α-synuclein pathology
Yin, S., Chi, X., Wan, F. J., Li, Y., Zhou, Q., Kou, L., Sun, Y., Wu, J., Zou, W., Wang, Y., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113446 · Cited by 26
Immune Modulation in Alzheimer’s Disease: From Pathogenesis to Immunotherapy
Balkhi, S., Spirito, A. D., Poggi, A. D., & Mortara, L. (2025) · Cells · doi:10.3390/cells14040264 · Cited by 24
Ayyubova, G. (2023) · European Journal of Neuroscience · doi:10.1111/ejn.15914 · Cited by 23
Španić, E., Leko, M. B., Horvat, L. L., Brgić, K., Vogrinc, Ž., Boban, M., Klepac, N., Borovečki, F., & Šimić, G. (2023) · Neurology International · doi:10.3390/neurolint15030053 · Cited by 21
Neuroinflammation: The Abused Concept
Galea, E., & Graeber, M. B. (2023) · ASN NEURO · doi:10.1177/17590914231197523 · Cited by 22
He, D., Liu, Q., Mi, Y., Meng, Q., Xu, L., Hou, C., Wang, J., Li, N., Liu, Y., Chai, H., et al. (2024) · Advanced Science · doi:10.1002/advs.202307245 · Cited by 26
Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination
Hou, J., Magliozzi, R., Chen, Y., Wu, J., Wulf, J., Strout, G., Fang, X., & Colonna, M. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2426786122 · Cited by 20
“Although agonistic anti - TREM2 antibodies are currently being tested in preclinical studies and trials for AD ( 45 – 49 ), some of these therapeutics may also be suitable to facil itate myelin repair in demyelinating diseases.”
Self-citationPatir, A., Barrington, J., Szymkowiak, S., Brezzo, G., Straus, D., Alfieri, A., Lefèvre, L., Liu, Z., Ginhoux, F., Henderson, N. C., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114250 · Cited by 20
Quan, W., Luo, Q., Hao, W., Tomic, I., Furihata, T., Schulz‐Schaeffer, W., Menger, M. D., Fassbender, K. C., & Liu, Y. (2021) · Glia · doi:10.1002/glia.24007 · Cited by 20
Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomain
Szykowska, A., Chen, Y., Smith, T. B., Preger, C., Yang, J., Qian, D., Mukhopadhyay, S. M., Wigren, E., Neame, S. J., Gräslund, S., et al. (2021) · Structure · doi:10.1016/j.str.2021.06.010 · Cited by 19
The Dual Nature of Microglia in Alzheimer’s Disease: A Microglia-Neuron Crosstalk Perspective
Xie, Z., Meng, J., Wu, Z., Nakanishi, H., Hayashi, Y., Kong, W., Lan, F., Narengaowa, Yang, Q., Qing, H., et al. (2023) · The Neuroscientist · doi:10.1177/10738584211070273 · Cited by 19
New insights into innate immunity in Alzheimer’s disease: From APOE protective variants to therapies
Chen, Y., & Holtzman, D. M. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.08.001 · Cited by 19
Jiao, L., Yang, J., Wang, W., Liu, X., Fu, Y., & Fan, D. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1515252 · Cited by 19
Unraveling the Immune Puzzle: Role of Immunomodulation in Alzheimer’s Disease
Ashvin, Dhapola, R., Kumari, S., Sharma, P., Vellingiri, B., Medhi, B., & HariKrishnaReddy, D. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10210-9 · Cited by 19
Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone–Pyridylhydrazone Copper(II) Complex
Choo, X. Y., McInnes, L. E., Grubman, A., Wasielewska, J. M., Belaya, I., Burrows, E. L., Quek, H., Cañas-Martín, J., Loppi, S. H., Sorvari, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810722 · Cited by 20
Zhuang, J., Zhang, Y., Shu, H., Zhang, S., Zhao, W., Ward, N., & Wang, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03133-6 · Cited by 19
TREM2 and CD163 Ameliorate Microglia-Mediated Inflammatory Environment in the Aging Brain
Han, X., Liu, Y., Liu, B.-W., Ma, Z., Xia, T., & Gu, X. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-01965-4 · Cited by 19
Pathogenesis and therapeutic applications of microglia receptors in Alzheimer’s disease
Fu, J., Wang, R., He, J., Liu, X., Wang, X., Yao, J., Liu, Y., Ran, C., Ye, Q., & He, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1508023 · Cited by 25
TREM2 in cardiovascular diseases: Mechanisms and therapeutic perspectives
Zhu, W., Yue, Z., Wang, Y., Guo, L., & Liu, C. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102774 · Cited by 20
Macrophages: sentinels, warriors, and healers
Bernier, E., Bartnicki, E., & Khanna, K. M. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf087 · Cited by 20
Microglial phagocytosis in epilepsy: Mechanisms and impact
Barath, A. S., & Wu, L. (2025) · The Journal of Physiology · doi:10.1113/jp288573 · Cited by 18
Samuels, J. D., Lukens, J. R., & Price, R. J. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15981 · Cited by 23
Ramaswami, G., Yuva, Y., Akerberg, B. N., Matthews, B. J., Williams, J., Golczer, G., Huang, J., Abdullatif, A. A., Huh, D., Burkly, L. C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-52311-0 · Cited by 21
DAP12 interacts with RER1 and is retained in the secretory pathway before assembly with TREM2
Liu, Y., Theil, S., Ibach, M., & Walter, J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05298-w · Cited by 18
Cen, Y., Alves, S. R., Song, D., Felice, C., Preall, J. B., Aelst, L. V., & Tonks, N. K. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2521944123 · Cited by 19
Wang, Y., Wu, T. Z., Tsai, M., Rezzonico, M. G., Abdel‐Haleem, A. M., Xie, L., Gandham, V. D., Ngu, H., Stark, K. L., Glock, C., et al. (2023) · eLife · doi:10.7554/elife.83451 · Cited by 18
Immunological aspects of central neurodegeneration
Niso‐Santano, M., Fuentes, J. M., & Galluzzi, L. (2024) · Cell Discovery · doi:10.1038/s41421-024-00666-z · Cited by 21
Henningfield, C. M., Soni, N., Lee, R. W., Sharma, R. B., Cleland, J. L., & Green, K. N. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01470-3 · Cited by 19
Stem cell therapy in Alzheimer’s disease: current status and perspectives
Ou, C.-M., Xue, W.-W., Liu, D., Ma, L., Xie, H.-T., & Ning, K. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1440334 · Cited by 19
Refining the interactions between microglia and astrocytes in Alzheimer’s disease pathology
Chen, J., Xu, S., Wang, L., Liu, X., Liu, G., Tan, Q., Li, W., Zhang, S., & Du, Y. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.033 · Cited by 17
Ube2c-inhibition alleviated amyloid pathology and memory deficits in APP/PS1 mice model of AD
Li, T., Su, Q., Zhang, Z., Zhang, Y., Yang, M., Wang, Z., Guo, J., Wang, Z., Wu, M., Cai, H.-Y., et al. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102298 · Cited by 18
Wang, S., & Colonna, M. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1200 · Cited by 17
Self-citationTREM2 as an evolving therapeutic target in Alzheimer’s disease
George, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371360 · Cited by 17
The various roles of TREM2 in cardiovascular disease
Wang, S., Cao, C., & Peng, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1462508 · Cited by 21
Self-citationEfferocytosis in Health and Disease
Li, C., Yang, Y., Zhou, F., Jiang, Q., Jiang, Y., Huang, X., Zhang, Y., Ye, Z., Xu, G. X., Kao, G., et al. (2025) · MedComm · doi:10.1002/mco2.70546 · Cited by 24
Therapeutic targeting of neuroimmune mechanisms in neurodegeneration
Monroe, K. M., Hong, S. Y., Lewcock, J. W., & Yang, A. C. (2026) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01370-7 · Cited by 16
Alzheimer’s disease: Pathophysiology and dental pulp stem cells therapeutic prospects
Xiong, W., Liu, Y., Zhou, H., Jing, S., He, Y., & Ye, Q. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999024 · Cited by 17
Therapeutic Targets in Innate Immunity to Tackle Alzheimer’s Disease
Serradas, M. L., Ding, Y., Martorell, P., Kulińska, I., & Castro‐Gomez, S. (2024) · Cells · doi:10.3390/cells13171426 · Cited by 17
Therapies for Tau-associated neurodegenerative disorders: targeting molecules, synapses, and cells
Robbins, M. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.373670 · Cited by 16
Paradigm Shift: Multiple Potential Pathways to Neurodegenerative Dementia
Perna, A., Montine, K. S., White, L. R., Montine, T. J., & Cholerton, B. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01441-w · Cited by 16
As48, a first-in-class dual-function TREM2 modulator: Receptor activation and shedding inhibition
Cho, S., Gaamouch, F. E., Upadhyay, S., Nada, H., Kuncewicz, K., & Gabr, M. T. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118862 · Cited by 17
The Critical Role of Biomarkers for Drug Development Targeting the Biology of Aging
Owen, M., Bose, N., Nisenbaum, L., Partrick, K. A., & Fillit, H. M. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.111 · Cited by 16
Type I Interferon Signalling and Ischemic Stroke: Mechanisms and Therapeutic Potentials
Cui, P., Song, B., Xia, Z., & Xu, Y. (2024) · Translational Stroke Research · doi:10.1007/s12975-024-01236-x · Cited by 18
Alzheimer’s disease and immunotherapy
Qin, W., Pang, Y., Nie, S., Quan, M., & Jia, J. (2024) · Current Medicine · doi:10.1007/s44194-024-00035-8 · Cited by 16
Ma, W., Zhao, L., Xu, B., Fariss, R. N., Redmond, T. M., Zou, J., Wong, W. T., & Li, W. (2024) · eLife · doi:10.7554/elife.90695.3 · Cited by 16
Farzan, M., Rounkian, M. S., Rizi, A. A., Heidari, Z., Farzan, M., Fathi, M., Aghaei, A., Azadegan‐Dehkordi, F., & Bagheri, N. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115071 · Cited by 16
Microglial Modulation in Alzheimer’s Disease: Central Players in Neuroinflammation and Pathogenesis
Hussain, M. S., Khan, Y., Fatima, R., Maqbool, M., Ramalingam, P. S., Khan, M. G., & Bisht, A. S. (2025) · Current Alzheimer Research · doi:10.2174/0115672050364292250113063513 · Cited by 18
Wang, T., Liu, X., Wang, X., Hua, F., & Yan, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1739875 · Cited by 14
“This signaling pathway enables microglia to acquire a protective transcriptional signature essential for their normal surveillance functions (13, 18).”
Pilat, D. J., Le, H., Prokopenko, D., Lin, C.-C. J., Eimer, W. A., Quinti, L., Gavrilles, E. P., Garcia, S. N., Heitman, S. N., McGinty, D., et al. (2026) · Neuron · doi:10.1016/j.neuron.2025.09.032 · Cited by 14
Topalis, V., Voros, C., & Ziaka, M. (2025) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887251361578 · Cited by 16
Jiao, H., Ge, Y., Huang, L.-Y., Liu, Y., Wu, B., Lian, P., Hao, Y., Han, S., Li, Y., Wu, K., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00887-0 · Cited by 14
Zhang, L., Wang, S., Ding, Y., Zheng, T., Sheng, J., Chen, Y., Wang, Z., Dai, X., Wang, C., Ma, L., et al. (2025) · Theranostics · doi:10.7150/thno.118014 · Cited by 16
Self-citationContextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease
Lalwani, R. C., Volmar, C., Wahlestedt, C., Webster, K. A., & Shehadeh, L. A. (2023) · Biomedicines · doi:10.3390/biomedicines11123232 · Cited by 15
Role of TREM2 in immune and neurological diseases: Structure, function, and implications
Yin, P., Su, Z., Shu, X., Dong, Z., & Tian, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113286 · Cited by 16
Larson, K. C., Gergits, F. W., Renoux, A. J., Weisman, E. J., Dejanovic, B., Huang, L., Pandya, B. A., McLaren, D. G., Lynch, B. A., Fisher, R., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03346-1 · Cited by 14
Decoding microglial functions in Alzheimer’s disease: insights from human models
Rao, C., Semrau, S., & Fossati, V. (2025) · Trends in Immunology · doi:10.1016/j.it.2025.02.011 · Cited by 14
Kraller, M., Faßbender, J., Jabali, A., Kroeger, J. A., Fink, B., Popper, B., Ungerer, M., & Christlmeier, M. A. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01759-x · Cited by 17
Romero‐Molina, C., Navarro, V., Jiménez, S., Muñoz‐Castro, C., Sanchez-Mico, M. V., Gutiérrez, A., Vitórica, J., & Vizuete, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189734 · Cited by 16
Fighting fire with fire: The immune system might be key in our fight against Alzheimer’s disease
Dujardin, P., Vandenbroucke, R. E., & Hoecke, L. V. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.01.004 · Cited by 15
Boudesco, C., Nonneman, A., Cinti, A., Picardi, P., Redaelli, L., Swijsen, S., Roewe, J., Reinhardt, P., Ibach, M., Walter, J., et al. (2022) · Glia · doi:10.1002/glia.24252 · Cited by 15
Role of TREM2 in the Development of Neurodegenerative Diseases After Traumatic Brain Injury
Zhang, C., & Chen, S. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-03094-w · Cited by 14
Shen, Z., Yang, X., Lan, Y., & Chen, G. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231159 · Cited by 14
Wang, S., Liu, Y., Li, X., Algradi, A. M., Jiang, H., Sun, Y., Guan, W., Pan, J., Kuang, H., & Yang, B. (2021) · Molecules · doi:10.3390/molecules26195946 · Cited by 15
Self-citationMackey-Alfonso, S. E., & Barrientos, R. M. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70911 · Cited by 15
Basic Microglial Functions and How They Go Awry in Neurodegenerative Disease
McKinney, J. E., Bennett, M. L., & Bennett, F. C. (2026) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-042624-114332 · Cited by 16
Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
Rudman, M. D., Ulrich, J. D., & Holtzman, D. M. (2026) · Cell · doi:10.1016/j.cell.2026.06.006 · Cited by 19
Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates
Hroudová, J., & Fišar, Z. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111069 · Cited by 13
Stevenson, M. E., Algarzae, N. K., & Moussa, C. (2024) · Frontiers in Dementia · doi:10.3389/frdem.2024.1458038 · Cited by 15
Phase 1, First‐In‐Human, Single‐/Multiple‐Ascending Dose Study of Iluzanebart in Healthy Volunteers
Meier, A., Papapetropoulos, S., Marsh, A., Neelon, K., Stiles, D. A., O'Mara, R., Thackaberry, E. A., Colonna, M., & Rajagovindan, R. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70033 · Cited by 13
Self-citationLi, J., Wang, Z., Zhang, Y., Li, Y., Feng, L., Wang, J., Wang, J., Zhou, Z., Zhang, Y., & Chang, X. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118602 · Cited by 16
Metadata
- Authors
- Wang, S., Mustafa, M., Yuede, C. M., Salazar, S. V., Kong, P., Long, H., Ward, M., Siddiqui, O., Paul, R., Gilfillan, S., Ibrahim, A., Rhinn, H., Tassi, I., Rosenthal, A., Schwabe, T., & Colonna, M.
- Affiliations
- Washington University in St. Louis (US)
- Alector (United States) (US)
- Corresponding author
- Schwabe, Tina
- Colonna, Marco
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2020-06-24
- Volume
- 217
- Issue
- 9
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC7478730
- OpenAlex
- W3037497912
- Cited by
- 549
- References
- 41
- Citations by year
- 2026: 106 · 2025: 115 · 2024: 101 · 2023: 93 · 2022: 64 · 2021: 52 · 2020: 18
- FWCI
- 21.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (RF1AG05148501, R21 AG059176, RF1 AG059082)
- Cure Alzheimer’s Fund
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- TREM2, Alzheimer's disease, microglial proliferation, amyloid plaques, microglial inflammation, transgenic mouse model, single-cell RNA sequencing, cerebrospinal fluid biomarkers, immunotherapy
- MeSH terms
- Alzheimer Disease, Animals, Antibodies, Monoclonal, Anxiety, Blood-Brain Barrier, Disease Models, Animal, Humans, Membrane Glycoproteins, Mice, Inbred C57BL, Mice, Transgenic, Protein Conformation, Receptors, Immunologic, Solubility, Signal Transduction, Biomarkers, Amyloid beta-Peptides, Neurites, Microglia, Cell Proliferation, Osteopontin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.